Answers are grounded in this paper and cite their sources.
Nationwide epidemiologic study reveals relapsing-remitting multiple sclerosis incidence and prevalence patterns, highlighting disparities between public and private healthcare sectors.
Multiple sclerosis (MS) is a chronic neuroinflammatory disease, yet comprehensive, nationwide epidemiologic data from Chile remain scarce. We aim to estimate the national incidence and prevalence of administratively identified relapsing-remitting MS (RRMS) in Chile from 2010 to 2023, characterize demographic patterns, and quantify disparities across the nation's segmented public and private health care systems.
No takes yet. Share an insight, caveat, or question.
Valdés et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: